Veru (VERU)

• Market cap: $39.2M
• 1 day: 0.83%
• 5 days: -0.41%
• 1 month: -4.69%
• 3 months: -26.06%
• 6 months: -62.63%
• Year to date: -62.58%
• 1 year: -66.58%
• 5 years: -92.61%
• 10 years: -84.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Employees: 210